This study is testing whether adding the drug alpelisib to standard hormone therapy can help control advanced breast cancer that has a specific genetic change (PIK3CA mutation) and has stopped responding to hormone therapy alone. It will involve about 44 adults with this type of …
Phase: PHASE2 • Sponsor: Marina N Sharifi • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC